Elsevier Science Inc.
Comparative Risk of Venous Thromboembolism for Chlormadinone Acetate- and Levonorgestrel-Containing Combined Oral Contraceptives
A recent study assessing the risk of venous thromboembolism (VTE) for two types of combined oral contraceptives (COCs) has found comparable incidence rates between chlormadinone acetate (CMA) 2 mg/ethinylestradiol (EE) 30 g and levonorgestrel (LNG) 0.15 mg/EE 30 g. The research, conducted by P. De Corte and